InsiderClue
Insiders · Profile

SULLIVAN LOUIS W

Director at UNITED THERAPEUTICS · Director at Emergent BioSolutions · Director at Henry Schein · and 1 more. Filing since 11 Dec 2007. CIK 0001193522

UTHR UNITED THERAPEUTICS Corp Director · 22 trades EBS Emergent BioSolutions Inc. Director · 9 trades HSIC Henry Schein Director · 6 trades ANIP ANI PHARMACEUTICALS INC Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
UTHR UNITED THERAPEUTICS Corp
22 Dec 2025
Director
Sold at will
5,950
$3.05M
100%
UTHR UNITED THERAPEUTICS Corp
18 Dec 2024
Director
Sold at will
26,209
$9.78M
83.8%
UTHR UNITED THERAPEUTICS Corp
3 May 2024
Director
Sold at will
5,160
$1.33M
28.3%
UTHR UNITED THERAPEUTICS Corp
1 Mar 2023
Director
Sold, plan not stated
700
$171.57K
5.4%
UTHR UNITED THERAPEUTICS Corp
1 Feb 2023
Director
Sold, plan not stated
700
$182.93K
5.4%
UTHR UNITED THERAPEUTICS Corp
3 Jan 2023
Director
Sold, plan not stated
700
$193.38K
5.4%
UTHR UNITED THERAPEUTICS Corp
1 Dec 2022
Director
Sold, plan not stated
700
$195.92K
5.4%
UTHR UNITED THERAPEUTICS Corp
1 Nov 2022
Director
Sold, plan not stated
700
$161.20K
5.4%
UTHR UNITED THERAPEUTICS Corp
3 Oct 2022
Director
Sold, plan not stated
710
$150.21K
5.5%
UTHR UNITED THERAPEUTICS Corp
2 Sep 2022
Director
Sold, plan not stated
4,910
$1.11M
28.7%
UTHR UNITED THERAPEUTICS Corp
26 May 2022
Director
Sold, plan not stated
6,310
$1.42M
36.2%
EBS Emergent BioSolutions Inc.
2 Sep 2020
Director
Sold, plan not stated
28,418
$3.16M
39.9%
EBS Emergent BioSolutions Inc.
4 Mar 2020
Director
Sold, plan not stated
15,786
$930.71K
20.7%
EBS Emergent BioSolutions Inc.
13 May 2016
Director
Sold, plan not stated
25,731
$1.01M
47.4%
EBS Emergent BioSolutions Inc.
13 May 2016
Director
Bought
21,600
$846.50K
313%
EBS Emergent BioSolutions Inc.
12 May 2016
Director
Sold, plan not stated
300
$11.70K
1.0%
EBS Emergent BioSolutions Inc.
11 May 2016
Director
Sold, plan not stated
9,969
$391.28K
25.9%
EBS Emergent BioSolutions Inc.
11 Mar 2016
Director
Sold, plan not stated
14,879
$506.33K
34.3%
EBS Emergent BioSolutions Inc.
10 Mar 2016
Director
Sold, plan not stated
14,820
$523.74K
34.2%
HSIC Henry Schein
2 Mar 2016
Director
Sold, plan not stated
11,735
$1.98M
47.5%
HSIC Henry Schein
17 Nov 2015
Director
Sold, plan not stated
15,622
$2.41M
47.2%
UTHR UNITED THERAPEUTICS Corp
18 Jun 2015
Director
Sold, plan not stated
15,000
$2.78M
100%
EBS Emergent BioSolutions Inc.
16 Jun 2015
Director
Sold, plan not stated
13,457
$421.54K
32.1%
HSIC Henry Schein
29 Aug 2014
Director
Sold, plan not stated
17,262
$2.07M
47.4%
UTHR UNITED THERAPEUTICS Corp
22 May 2014
Director
Sold, plan not stated
30,000
$3.04M
100%
HSIC Henry Schein
13 May 2014
Director
Sold, plan not stated
1,638
$190.03K
6.8%
UTHR UNITED THERAPEUTICS Corp
30 Sep 2013
Director
Sold, plan not stated
42,000
$3.30M
100%
HSIC Henry Schein
20 Aug 2013
Director
Sold, plan not stated
15,000
$1.56M
41.7%
ANIP ANI PHARMACEUTICALS INC
15 Aug 2011
Director
Bought
10,000
$26.70K
26.4%
UTHR UNITED THERAPEUTICS Corp
2 May 2011
Director
Sold, plan not stated
6,000
$401.76K
100%
HSIC Henry Schein
15 Mar 2011
Director
Sold, plan not stated
19,500
$1.28M
52.4%
UTHR UNITED THERAPEUTICS Corp
1 Mar 2011
Director
Sold, plan not stated
6,000
$404.33K
100%
ANIP ANI PHARMACEUTICALS INC
13 Jan 2011
Director
Bought
10,000
$17.20K
35.8%
UTHR UNITED THERAPEUTICS Corp
3 Jan 2011
Director
Sold, plan not stated
6,000
$383.59K
100%
UTHR UNITED THERAPEUTICS Corp
29 Oct 2010
Director
Sold, plan not stated
5,600
$336.00K
100%
UTHR UNITED THERAPEUTICS Corp
28 Oct 2010
Director
Sold, plan not stated
400
$24.00K
100%
UTHR UNITED THERAPEUTICS Corp
12 Aug 2010
Director
Sold, plan not stated
24,000
$1.21M
100%
UTHR UNITED THERAPEUTICS Corp
9 Aug 2010
Director
Sold, plan not stated
1,282
$66.47K
100%
UTHR UNITED THERAPEUTICS Corp
11 Dec 2007
Director
Sold, plan not stated
20,213
$2.13M
100%
39 decisions on file.